Jonathan Quick
Corporate Officer/Principal bei LOGICBIO THERAPEUTICS, INC.
Profil
Jonathan Quick is currently working as the Vice President-Finance at LogicBio Therapeutics, Inc. He previously worked as the Director-Financial Reporting, Planning & Analysis at Celldex Therapeutics, Inc. and as the Director-SEC Reporting & Technical Accounting at Karyopharm Therapeutics, Inc. Mr. Quick completed his undergraduate degree at Providence College.
Aktive Positionen von Jonathan Quick
| Unternehmen | Position | Beginn |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jonathan Quick
| Unternehmen | Position | Ende |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Jonathan Quick
| Providence College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
